
Synthesis p. 1257 - 1262 (1995)
Update date:2022-08-05
Topics: Synthesis Regioselectivity Melting point Yield NMR spectroscopy Catalyst Bioassay Solvent Stereochemistry Chromatography Mass spectrometry (MS) Purification Scale-up Reaction Mechanism Structure-Activity Relationship (SAR) Reaction Optimization Purity Receptor antagonist IC50
Sugaya
Kato
Sakaguchi
Tomioka
Two derivatives of sodium (E)-11-[2-(1-benzimidazolyl)ethylidene]11-oxo-6,11-dihydrodibenz[b,e]o xepin-2-carboxylate, novel nonprostanoid thromboxane A2 (TXA2) receptor antagonists, were synthesized from methyl 11-oxo-6,11-dihydrodibenz[b,e]oxepin-2-carboxylate. The carbonyl group at C11 was converted into a formylmethylene, then into a 1-azadiene moiety by reaction with a 2-aminoformanilide derivative. Stereo- and regioselective elaboration of the unsymmetrical imidazoles was achieved through a sequence of the transformation of E,Z-1-azadiene intermediates to E isomers under acidic conditions followed by cyclization to imidazoles.
View MoreSICHUAN ZHONGBANG NEW MATERIAL CO., LTD
website:http://www.zhongbangst.com
Contact:86-830-2585019
Address:sichuan,china
Contact:86-379-63338609
Address:Jiudian Village,Deting Town,Song County,Luoyang
Penglai Qianwei Chemical Co., Ltd.
Contact:86-535-3357802
Address:Shahelu (north), Penglai, Shandong, China
Guangxi Bonger Pharmaceutical Co., Ltd
website:http://napo.lookchem.com/
Contact:+86-18817331185
Address:Donghai Industrial Zone, Tiandong Country,Guangxi,China
Shenzhen HwaGen Pharmaceutical Co., Ltd
website:http://www.rafflespt.com
Contact:+86-752-5538396
Address:Guangdong Huizhou China
Doi:10.1016/j.bmc.2010.12.051
(2011)Doi:10.1021/om00156a030
(1990)Doi:10.1016/j.jorganchem.2010.10.066
(2011)Doi:10.1002/chir.22429
(2015)Doi:10.1039/c39890001881
(1989)Doi:10.1016/S0040-4039(01)88999-1
(1989)